Skip to main content
Key Specialties
Cardiology Diabetology Endocrinology Gastroenterology Geriatrics and Gerontology Gynecology and Obstetrics Hematology Infectious Disease Internal Medicine Nephrology Neurology Oncology Pediatrics Respiratory Medicine Rheumatology Surgery
Congress Coverage
2024 ACC Congress 2023 ESMO Congress 2023 EASD Congress 2023 ERS Congress 2023 ESC Congress
Clinical Collections
Advances in Alzheimer’s

Keynote webinar | Spotlight on medication adherence

LIVE: Thursday 27th June 2024, 18:00-19:30 (CEST)
Join our expert panel to discover why you need to understand the drivers of non-adherence in your patients, and how you can optimize medication adherence in your clinics to drastically improve patient outcomes.
ADVANCED SEARCH
Log in
Top
Clinical and Experimental Nephrology
Published in: Clinical and Experimental Nephrology 3/2007

01-09-2007 | CASE REPORT

Sirolimus for visceral and cutaneous Kaposi's sarcoma in a renal-transplant recipient

Authors: Osama Gheith, Adel Bakr, Ehab Wafa, Ashraf Fouda, Amgad El Agroudy, Ayman Refaie, Ahmed Donia, Alaa Sabry, Mohamed Sobh, Ahmed Shokeir, Mohamed Ghoneim

Published in: Clinical and Experimental Nephrology | Issue 3/2007

Login to get access
Metadata
Title
Sirolimus for visceral and cutaneous Kaposi's sarcoma in a renal-transplant recipient
Authors
Osama Gheith
Adel Bakr
Ehab Wafa
Ashraf Fouda
Amgad El Agroudy
Ayman Refaie
Ahmed Donia
Alaa Sabry
Mohamed Sobh
Ahmed Shokeir
Mohamed Ghoneim
Publication date
01-09-2007
Publisher
Springer Japan
Published in
Clinical and Experimental Nephrology / Issue 3/2007
Print ISSN: 1342-1751
Electronic ISSN: 1437-7799
DOI
https://doi.org/10.1007/s10157-007-0470-y

Other articles of this Issue 3/2007

Clinical and Experimental Nephrology 3/2007 Go to the issue

CASE REPORT

Severe metabolic acidosis and hypokalemia in a patient with enterovesical fistula

CASE REPORT

Reversible acute renal failure associated with clomipramine-induced interstitial nephritis

ORIGINAL ARTICLE

An angiotensin II type-I receptor blocker, olmesartan medoxomil, attenuates lipid peroxidation in renal injury induced by subtotal nephrectomy

ORIGINAL ARTICLE

Transcriptional repression mediated by 45-kDa calcium oxalate monohydrate binding protein

CASE REPORT

Acute renal failure due to interstitial nephritis after intravesical instillation of BCG

ORIGINAL ARTICLE

Reduction of serum antioxidative capacity during hemodialysis
Live Webinar | 27-06-2024 | 18:00 (CEST)

Keynote webinar | Spotlight on medication adherence

Reserve your place

Live: Thursday 27th June 2024, 18:00-19:30 (CEST)

WHO estimates that half of all patients worldwide are non-adherent to their prescribed medication. The consequences of poor adherence can be catastrophic, on both the individual and population level.

Join our expert panel to discover why you need to understand the drivers of non-adherence in your patients, and how you can optimize medication adherence in your clinics to drastically improve patient outcomes.

Prof. Kevin Dolgin
Prof. Florian Limbourg
Prof. Anoop Chauhan
Developed by: Springer Medicine
Obesity Clinical Trial Summary

At a glance: The STEP trials

Read more

A round-up of the STEP phase 3 clinical trials evaluating semaglutide for weight loss in people with overweight or obesity.

Developed by: Springer Medicine
Image Credits